273 studies found for:    Central Cord Syndrome
Show Display Options
RSS Create an RSS feed from your search for:
Central Cord Syndrome
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Unknown  Surgical Management of Spinal Cord Injuries In Neck
Conditions: Central Cord Syndrome;   Spinal Cord Injury;   Quadriparesis
Intervention: Procedure: Early and late surgery for traumatic central cord syndrome
2 Unknown  The Natural History of Traumatic Spinal Cord Injury Using fMRI, MRS and DTI
Condition: Central Cord Syndrome
Intervention:
3 Recruiting Comparing Surgical Decompression Versus Conservative Treatment in Incomplete Spinal Cord Injury
Condition: Central Spinal Cord Syndrome
Interventions: Procedure: Surgical decompression;   Procedure: Conservative treatment
4 Terminated Intermittent Positive-Pressure Breathing Effects in Patients With High Spinal Cord Injury
Conditions: Central Cord Injury Syndrome;   Central Spinal Cord Syndrome
Intervention: Device: intermittent positive-pressure breathing (IPPB)
5 Unknown  Retraining Walking After Spinal Cord Injury
Conditions: Spinal Cord Injuries;   Quadriplegia;   Paraplegia;   Central Cord Syndrome;   Brown-Sequard Syndrome
Intervention: Behavioral: Locomotor treadmill training with body weight support
6 Active, not recruiting Effects of Breathing and Walking Treatments on Recovery Post-Spinal Cord Injury
Conditions: Spinal Cord Injuries;   Brown Sequard;   Central Cord Syndrome
Interventions: Other: Breathing (Hypoxia) Treatment;   Other: Breathing (Hypoxia) Treatment and Locomotor Training
7 Recruiting Effect of Acetazolamide & Position in CSF Leakage and Collection and Wound Dehiscence
Conditions: Tethered Cord Syndrome;   Split Cord Malformation;   Lipoma of Spinal Cord
Interventions: Drug: Acetazolamide;   Other: prone positioning;   Other: Acetazolamide+ prone positioning
8 Recruiting Deep rTMS in Central Neuropathic Pain Syndromes
Conditions: Pain;   Spinal Cord Injury;   Post Stroke Pain
Intervention: Device: deep rTMS
9 Recruiting Donor Umbilical Cord Blood Transplant With or Without Ex-Vivo Expanded Cord Blood Progenitor Cells in Treating Patients With Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Chronic Myelogenous Leukemia, or Myelodysplastic Syndromes
Conditions: Accelerated Phase Chronic Myelogenous Leukemia;   Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic Syndrome;   Adult Acute Lymphoblastic Leukemia in Remission;   Adult Acute Myeloid Leukemia in Remission;   Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities;   Adult Acute Myeloid Leukemia With Del(5q);   Adult Acute Myeloid Leukemia With Inv(16)(p13;q22);   Adult Acute Myeloid Leukemia With t(15;17)(q22;q12);   Adult Acute Myeloid Leukemia With t(16;16)(p13;q22);   Adult Acute Myeloid Leukemia With t(8;21)(q22;q22);   Childhood Acute Lymphoblastic Leukemia in Remission;   Childhood Acute Myeloid Leukemia in Remission;   Childhood Chronic Myelogenous Leukemia;   Chronic Phase Chronic Myelogenous Leukemia;   de Novo Myelodysplastic Syndromes;   Previously Treated Myelodysplastic Syndromes;   Refractory Anemia;   Refractory Anemia With Excess Blasts;   Refractory Anemia With Excess Blasts in Transformation;   Relapsing Chronic Myelogenous Leukemia;   Secondary Acute Myeloid Leukemia
Interventions: Drug: fludarabine phosphate;   Drug: cyclophosphamide;   Radiation: total-body irradiation;   Procedure: ex vivo-expanded cord blood progenitor cell infusion;   Procedure: umbilical cord blood transplantation;   Procedure: double-unit umbilical cord blood transplantation;   Drug: cyclosporine;   Drug: mycophenolate mofetil;   Other: laboratory biomarker analysis
10 Recruiting Combination Chemotherapy Followed By Donor Umbilical Cord Blood Transplant in Treating Infants With High-Risk Acute Leukemia or Myelodysplastic Syndromes
Conditions: Leukemia;   Myelodysplastic Syndromes
Interventions: Biological: filgrastim;   Drug: busulfan;   Drug: cyclosporine;   Drug: fludarabine phosphate;   Drug: melphalan;   Drug: mycophenolate mofetil;   Procedure: umbilical cord blood transplantation
11 Terminated
Has Results
Donor Umbilical Cord Blood Natural Killer Cells, Aldesleukin and Umbilical Cord Blood Transplant in Patients With Refractory Hematologic Cancers.
Conditions: Leukemia;   Myelodysplastic Syndromes
Interventions: Biological: aldesleukin;   Biological: filgrastim;   Biological: natural killer cell (NK) therapy;   Drug: cyclophosphamide;   Drug: cyclosporine;   Drug: fludarabine phosphate;   Drug: methylprednisolone;   Drug: mycophenolate mofetil;   Procedure: Umbilical Cord Blood Transplantation (UCBT);   Radiation: Total body irradiation (TBI)
12 Recruiting Myeloablative Umbilical Cord Blood Transplantation in Hematological Diseases
Conditions: Acute Myeloid Leukemia;   Acute Lymphocytic Leukemia;   Chronic Myelogenous Leukemia;   Myelofibrosis;   MDS;   Refractory Anemia;   Chronic Lymphocytic Leukemia;   Prolymphocytic Leukemia;   Non-Hodgkin's Lymphoma;   Leukemia;   Lymphoma;   Multiple Myeloma;   Myelodysplastic Syndromes
Interventions: Biological: filgrastim;   Drug: cyclophosphamide;   Drug: cyclosporine;   Drug: fludarabine phosphate;   Drug: mycophenolate mofetil;   Procedure: umbilical cord blood transplantation;   Radiation: total-body irradiation
13 Terminated Extension Study of Intrathecal Enzyme Replacement Therapy for MPS I
Conditions: Spinal Cord Compression;   Mucopolysaccharidosis I;   Hurler-Scheie Syndrome;   Scheie Syndrome;   Lysosomal Storage Disease
Intervention: Drug: laronidase
14 Recruiting Treatment of Persistent Urinary Incontinence in Children
Condition: Urinary Incontinence
Interventions: Procedure: Surgery;   Procedure: Medical Treatment
15 Recruiting Stem Cell Transplant Using Peripheral and Cord Blood Stem Cells to Treat Severe Aplastic Anemia and Myelopdysplastic Syndrome
Conditions: Myelodysplastic Syndrome (MDS);   Severe Aplastic Anemia (SAA)
Interventions: Other: Umbilical Cord Blood;   Other: Haploidentical Stem Cells;   Device: Miltenvi CliniMACs CD34 Reagent System
16 Active, not recruiting Single Versus Double Umbilical Cord Blood Transplantation in Children With High Risk Leukemia and Myelodysplasia
Conditions: Acute Myelogenous Leukemia;   Acute Lymphocytic Leukemia;   Chronic Myelogenous Leukemia;   Myelodysplastic Syndrome;   NK Cell Lymphoblastic Leukemia
Interventions: Biological: Single Cord Blood Unit Transplantation;   Biological: Double Cord Blood Unit Transplantation
17 Terminated
Has Results
Treatment of Single or Double Umbilical Cord Trans + Graft-versus-host Disease (GVHD) Prophylaxis w/ Tacrolimus & Mycophenolate Mofetil
Conditions: Graft Versus Host Disease;   Leukemia;   Lymphoma;   Multiple Myeloma and Plasma Cell Neoplasm;   Myelodysplastic Syndromes
Interventions: Biological: anti-thymocyte globulin;   Drug: cyclophosphamide;   Drug: fludarabine phosphate;   Drug: methylprednisolone;   Radiation: total-body irradiation
18 Completed Umbilical Cord Blood Transplantation in Treating Patients With Hematologic Cancer or Nonmalignant Hematologic Disease
Conditions: Leukemia;   Lymphoma;   Myelodysplastic Syndromes;   Myelodysplastic/Myeloproliferative Diseases
Interventions: Biological: anti-thymocyte globulin;   Biological: filgrastim;   Drug: busulfan;   Drug: cyclophosphamide;   Drug: methylprednisolone;   Procedure: umbilical cord blood transplantation;   Radiation: radiation therapy
19 Completed Cyproheptadine and Megestrol in Preventing Weight Loss in Children With Cachexia Caused By Cancer or Cancer Treatment
Conditions: Brain Tumor;   Central Nervous System Tumors;   Cachexia;   Leukemia;   Lymphoma;   Myelodysplastic Syndromes;   Myelodysplastic/Myeloproliferative Diseases;   Unspecified Childhood Solid Tumor, Protocol Specific
Interventions: Drug: cyproheptadine hydrochloride;   Drug: megestrol acetate
20 Completed Umbilical Cord Blood Transplantation in Treating Patients With High-Risk Hematologic Cancer
Conditions: Graft Versus Host Disease;   Leukemia;   Lymphoma;   Myelodysplastic Syndromes;   Myelodysplastic/Myeloproliferative Diseases
Interventions: Biological: anti-thymocyte globulin;   Drug: busulfan;   Drug: cyclosporine;   Drug: melphalan;   Drug: methylprednisolone;   Procedure: umbilical cord blood transplantation;   Radiation: radiation therapy

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
Indicates status has not been verified in more than two years